What is Scipher Medicine?
Scipher Medicine is a precision immunology company dedicated to providing patients with clear, data-driven answers regarding their treatment options. Leveraging its proprietary network medicine platform, Spectra, the company commercializes diagnostic tests that reveal an individual's unique molecular disease signature. This allows for the precise matching of patients with the most effective therapies from the outset, thereby optimizing treatment outcomes for autoimmune diseases. The molecular data generated by Scipher Medicine's tests also serves as a valuable resource for the discovery and development of novel therapeutics, positioning the company as a key innovator in both diagnostics and drug development. Its strategic partnerships with leading payers, healthcare providers, and pharmaceutical companies further solidify its market presence.
How much funding has Scipher Medicine raised?
Scipher Medicine has raised a total of $217.3M across 4 funding rounds:
Series B
$25M
Debt
$350K
Series C
$82M
Other Financing Round
$110M
Series B (2020): $25M with participation from Khosla Ventures, Optum Ventures, Tachyon Ventures, Northpond Ventures, and Granpool Innovative Investments
Debt (2020): $350K led by PPP
Series C (2021): $82M supported by Echo Health Ventures LLC, aMoon, Northpond Ventures LLC, Alumni Ventures, and Khosla Ventures
Other Financing Round (2022): $110M featuring Laurion Capital Management, Neuberger Berman, Hitachi Ventures, Cowen Healthcare Investments, and Monashee Investment Management
Key Investors in Scipher Medicine
Laurion Capital Management
Laurion Capital Management is a private hedge fund sponsor based out of New York, established in 2005. The firm conducts internal research, employing quantitative and qualitative analysis for investment decisions.
Neuberger Berman
Founded in 1939, Neuberger Berman is an independent, employee-controlled asset management company offering global investment solutions including equity, fixed income, and alternatives through various investment products. They are based in New York, New York.
Monashee Investment Management
Monashee Investment Management, founded in 2011 and based in Boston, Massachusetts, is a financial services company specializing in providing investment advice.
What's next for Scipher Medicine?
The substantial enterprise-level funding and recent strategic investment indicate a strong market validation for Scipher Medicine's innovative approach to precision immunology. This capital infusion is expected to accelerate the company's growth trajectory, enabling further development and commercialization of its Spectra platform and diagnostic tests. Strategic expansion into new therapeutic areas and geographical markets is likely, alongside continued investment in research and development to enhance its drug discovery capabilities. The company is well-positioned to solidify its leadership in personalized medicine, addressing unmet needs in autoimmune disease treatment and contributing to the advancement of pharmaceutical innovation.
See full Scipher Medicine company page
